0001144204-14-010903.txt : 20140221
0001144204-14-010903.hdr.sgml : 20140221
20140221060420
ACCESSION NUMBER: 0001144204-14-010903
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140219
FILED AS OF DATE: 20140221
DATE AS OF CHANGE: 20140221
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INNOVUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001411879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870324697
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4275 EXECUTIVE SQUARE, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-964-5123
MAIL ADDRESS:
STREET 1: 4275 EXECUTIVE SQUARE, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: North Horizon, Inc.
DATE OF NAME CHANGE: 20070910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Damaj Bassam
CENTRAL INDEX KEY: 0001478733
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52991
FILM NUMBER: 14631576
MAIL ADDRESS:
STREET 1: C/O BIO-QUANT, INC.
STREET 2: 6330 NANCY RIDGE DRIVE, SUITE 103
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
v369250_form4.xml
FORM 4
X0306
4
2014-02-19
0
0001411879
INNOVUS PHARMACEUTICALS, INC.
INNV
0001478733
Damaj Bassam
8204 CAMINITO SANTA LUZ WEST
6330 NANCY RIDGE DRIVE, SUITE 103
SAN DIEGO,
CA
92127 US
1
1
1
0
President and CEO
Common Stock
2014-02-19
4
C
0
1190411
0
A
1708265
D
Common Stock
129393
I
By spouse
Restricted Stock Unit
Common Stock
852272
6852272
D
Conversion of January 15, 2103 Line of Credit 8% Debenture at $0.40 per share.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Issued as a year end bonus pursuant to Reporting Person's employment agreement. The Reporting Person was granted a fully vested Restricted Stock Unit awarded on February 6, 2014. The Restricted Stocks Units will settle upon the earliest to occur of (1) the Reporting Person's service termination date, (ii) a change in control or (iii) February 6, 2021
/s/Randy Berholtz, Attorney-In-Fact
2014-02-20